Activity measurements and determination of nuclear decay data of 166Ho in the MRTDosimetry project

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00177016%3A_____%2F19%3AN0000075" target="_blank" >RIV/00177016:_____/19:N0000075 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.1016/j.apradiso.2019.108826" target="_blank" >https://doi.org/10.1016/j.apradiso.2019.108826</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.apradiso.2019.108826" target="_blank" >10.1016/j.apradiso.2019.108826</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Activity measurements and determination of nuclear decay data of 166Ho in the MRTDosimetry project

Popis výsledku v původním jazyce

Holmium-166 is a high-energy β−-emitter radionuclide (~ 1.8 MeV) with a short half-life that offers great potential as an alternative to 90Y for the treatment of liver cancer based on radioembolization. The possibility of quantitative Single Photon Emission Computed Tomography (SPECT) imaging of the main γ-ray emission at 80.6 keV, in addition to strong paramagnetic properties suitable for Magnetic Resonance Imaging (MRI), complement this therapeutic potential. The present paper describes the measurements carried out in three European radionuclide metrology laboratories for primary standardization of 166Ho and new determinations of X- and γ-ray photon-emission intensities in the framework of the European EMPIR project MRTDosimetry. New half-life measurements were also performed.

Název v anglickém jazyce

Activity measurements and determination of nuclear decay data of 166Ho in the MRTDosimetry project

Popis výsledku anglicky

Holmium-166 is a high-energy β−-emitter radionuclide (~ 1.8 MeV) with a short half-life that offers great potential as an alternative to 90Y for the treatment of liver cancer based on radioembolization. The possibility of quantitative Single Photon Emission Computed Tomography (SPECT) imaging of the main γ-ray emission at 80.6 keV, in addition to strong paramagnetic properties suitable for Magnetic Resonance Imaging (MRI), complement this therapeutic potential. The present paper describes the measurements carried out in three European radionuclide metrology laboratories for primary standardization of 166Ho and new determinations of X- and γ-ray photon-emission intensities in the framework of the European EMPIR project MRTDosimetry. New half-life measurements were also performed.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

10301 - Atomic, molecular and chemical physics (physics of atoms and molecules including collision, interaction with radiation, magnetic resonances, Mössbauer effect)

Projekt

<a href="/cs/project/8B16002" target="_blank" >8B16002: Metrology for clinical implementation of dosimetry in molecular radiotherapy</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Applied Radiation and Isotopes

ISSN

0969-8043

e-ISSN

—

Svazek periodika

153

Číslo periodika v rámci svazku

153

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

11

Strana od-do

108826

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85072021987